Maia Miguelez

Efficacy and Safety of Brexpiprazole for the Treatment of Borderline Personality Disorder: a 12-Week, Phase 2, Randomized, Double-Blind, Placebo-Controlled Study

Abstract: Background: Atypical antipsychotics may be efficacious in the treatment of borderline personality disorder (BPD). This double-blind, Phase 2 study (NCT04100096) evaluated the ef...

Liz Kelly ;

Maia Miguelez ;

01/19/2023

Safety and Tolerability of Brexpiprazole for the Treatment of Borderline Personality Disorder: a 12-Week, Flexible-Dose, Open-Label Extension Study

Abstract: Background: Atypical antipsychotics may be efficacious in the treatment of borderline personality disorder (BPD). This study assessed the safety, tolerability and efficacy of br...

Liz Kelly ;

Maia Miguelez ;

01/19/2023